Synthesis and Anti‐tumor Evaluation of B‐ring Modified Caged Xanthone Analogues of Gambogic Acid
Synthesis and Anti‐tumor Evaluation of B‐ring Modified Caged Xanthone Analogues of Gambogic Acid
复制标题
DOI:
10.1002/cjoc.201100045
复制
发表时间:
2012
影响因子:
5.4
通讯作者:
Xiang Li;Xiaojin Zhang;Xiaojian Wang;Nianguang Li;Changjun Lin;Yuan Gao;Zhuoqin Yu;Q. Guo;Q. You
中科院分区:
文献类型:
--
作者:
Xiang Li;Xiaojin Zhang;Xiaojian Wang;Nianguang Li;Changjun Lin;Yuan Gao;Zhuoqin Yu;Q. Guo;Q. You
Gambogic acid (GA,1), the most prominent member ofGarcinianatural products, has been reported to be a promising anti‐tumor agent. Previous studies have suggested that the planar B ring and the unique 4‐oxa‐tricyclo[4.3.1.03,7]dec‐2‐one caged motif were essential for anti‐tumor activity. To further explore the structure‐activity relationship (SAR) of cagedGarciniaxanthones, two new series of B‐ring modified caged GA analogues13a–13eand15a–15ewere synthesized utilizing a Claisen/Diel‐Alder cascade reaction. Subsequently, these compounds were evaluated for theirin vitroanti‐tumor activities against A549, MCF‐7, SMMC‐7721 and BGC‐823 cancer cell lines by MTT assay. Among them,13b–13eexhibited micromolar inhibition against several cancer cell lines, being approximately 2–4 fold less potent in comparison to GA. SAR analysis revealed that the peripheral gem‐dimethyl groups are essential for maintaining anti‐tumor activity and substituent group on C1 position of B‐ring has a significant effect on potency, while modifications at C‐2, C‐3 and C‐4 positions are relatively tolerated. These findings will enhance our understanding of the SAR ofGarciniaxanthones and lead to the development of simplified analogues as potential anti‐tumor agents.